S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
BATS:NURE

Nuveen Short-Term REIT ETF (NURE) Price, Holdings, & News

$30.68
-0.05 (-0.16%)
(As of 06/9/2023 ET)
Compare
Today's Range
$30.64
▼
$30.68
50-Day Range
$28.95
▼
$30.83
52-Week Range
$23.70
▼
$27.25
Volume
3,296 shs
Average Volume
N/A
Market Capitalization
$56.76 million
Assets Under Management
$56.90 million
Dividend Yield
2.96%
Net Expense Ratio
0.35%
ProfileChartHeadlinesHoldings
NURE stock logo

About Nuveen Short-Term REIT ETF (BATS:NURE)

The Nuveen Short-Term REIT ETF (NURE) is an exchange-traded fund that mostly invests in real estate equity. The fund tracks an index composed of U.S. REITs that typically have shorter-term lease durations than average. NURE was launched on Dec 19, 2016 and is managed by Nuveen.

Receive NURE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nuveen Short-Term REIT ETF and its competitors with MarketBeat's FREE daily newsletter.

NURE ETF News Headlines

June 8, 2023 | finance.yahoo.com
4 Top-Performing Real Estate ETFs You Should Consider
June 6, 2023 | finance.yahoo.com
NURE - Nuveen Short-Term REIT ETF
June 9, 2023 | Behind the Markets (Ad)
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
April 8, 2023 | seekingalpha.com
NURE: A Rare REIT ETF Built For An Uncertain Rate Environment
February 28, 2023 | benzinga.com
Nuveen Senior Income Fund Stock (NYSE:NSL), Short Interest Report
January 12, 2023 | benzinga.com
Peering Into AbbVie's Recent Short Interest
January 12, 2023 | seekingalpha.com
NURE Has Lost Its Luster As Inflation Fades, But Some Individual Holdings Look Nice
January 9, 2023 | benzinga.com
Nuveen Mortgage & Inc: Dividend Insights
June 9, 2023 | Behind the Markets (Ad)
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
January 9, 2023 | benzinga.com
Wednesday Is Your Last Chance To Buy Nuveen Dynamic Municipal Before The Dividend Payout
See More Headlines

NURE Price History

Fund Details

Issuer
Nuveen
Fund Name
Nuveen Short-Term REIT ETF
Tax Classification
Regulated Investment Company
Stock Exchange
BATS
Current Symbol
BATS:NURE
Inception Date
12/19/2016
Fund Manager
Philip James Campagna, Lei Liao
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Real Estate
Benchmark
Dow Jones U.S. Select Short-Term REIT Index
Category
Real Estate
Focus
Real Estate
Development Level
Developed Markets
Region
North America
Number of Holdings
37

Fund Statistics

Assets Under Management
$56.90 million
Average Daily Volume
$25,608.30
Discount/Premium
1.37%

Administrator, Advisor and Custodian

Administrator
Brown Brothers Harriman & Co.
Advisor
Nuveen Fund Advisors, LLC
Custodian
Brown Brothers Harriman & Co.
Distributor
Nuveen Securities, LLC
Transfer Agent
Brown Brothers Harriman & Co.
Trustee
N/A
Lead Market Maker
Latour Trading

Miscellaneous

Outstanding Shares
1,850,000
Beta
0.92
Creation Unit
50,000
Creation Fee
$500.00


Nuveen Short-Term REIT ETF Expenses

TypeNUREReal Estate ETFsReal Estate ETFsBATS ETFsAll ETFs
Management Fee0.35%0.45%0.43%0.53%0.50%
Other Expenses0.00%0.20%0.23%0.50%0.57%
Total Expense0.35%0.51%0.49%0.65%0.69%
Fee Waiver0.00%-0.21%-0.19%-0.38%-0.59%
Net Expense0.35%0.47%0.46%0.60%0.57%

Nuveen Short-Term REIT ETF (NURE) Holdings & Exposure

Top 10 NURE Holdings

NURE Sector Exposure

NURE Industry Exposure

Full Holdings Details













NURE ETF - Frequently Asked Questions

How have NURE shares performed in 2023?

Nuveen Short-Term REIT ETF's stock was trading at $28.42 at the beginning of the year. Since then, NURE shares have increased by 8.1% and is now trading at $30.7241.
View the best growth stocks for 2023 here.

What does NURE invest in?

Nuveen Short-Term REIT ETF is a real estate fund issued by Nuveen. NURE focuses on real estate investments and follows the Dow Jones U.S. Select Short-Term REIT Index. The fund's investments total to approximately $56.90 million assets under management.

What stocks does Nuveen Short-Term REIT ETF hold?

NURE invests in 37 holdings. Some of the stocks in their portfolio include Life Storage (LSI), Public Storage (PSA), American Homes 4 Rent (AMH), CubeSmart (CUBE), Extra Space Storage (EXR), Invitation Homes (INVH), Equity LifeStyle Properties (ELS), Sun Communities (SUI), AvalonBay Communities (AVB) and Equity Residential (EQR).

What is the management fee for Nuveen Short-Term REIT ETF?

Nuveen Short-Term REIT ETF's management fee is 0.35% and has no other recorded expenses or fee waivers. The net expense ratio for NURE is 0.35%.

What other stocks do shareholders of Nuveen Short-Term REIT ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nuveen Short-Term REIT ETF investors own include Walt Disney (DIS), Cedar Realty Trust (CDR), Coherent (COHR), Costco Wholesale (COST), Franco-Nevada (FNV), Gulfport Energy (GPOR), The Goldman Sachs Group (GS), Johnson & Johnson (JNJ), Pampa Energía (PAM) and Pinnacle Entertainment (PNK).

What is Nuveen Short-Term REIT ETF's stock symbol?

Nuveen Short-Term REIT ETF trades on the BATS under the ticker symbol "NURE."

Who are Nuveen Short-Term REIT ETF's major shareholders?

Nuveen Short-Term REIT ETF's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Bank of America Corp DE (11.15%), Hedeker Wealth LLC (6.46%), Van ECK Associates Corp (2.03%), LPL Financial LLC (1.85%), Tower Research Capital LLC TRC (1.67%) and AE Wealth Management LLC (1.41%).

How do I buy shares of Nuveen Short-Term REIT ETF?

Shares of NURE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Nuveen Short-Term REIT ETF's stock price today?

One share of NURE stock can currently be purchased for approximately $30.72.

How much money does Nuveen Short-Term REIT ETF make?

Nuveen Short-Term REIT ETF (BATS:NURE) has a market capitalization of $56.84 million.

This page (BATS:NURE) was last updated on 6/9/2023 by MarketBeat.com Staff

My Account -